Leo Varadkar (Dublin West, Fine Gael) | Oireachtas source

I do not suggest that there is in this case. This is a company that is very aggressive in the way it prices its medicines. The door is never closed to a new medicine. The company can present new evidence, a better price, or both. I call on the Seanad to stand behind the taxpayer in the interests of patients as a whole and support the HSE national drugs committee in its efforts to ensure a fair price for this medicine. Even though I have no direct role in this matter at all, and do not make decisions under legislation, I am of course happy to discuss the matter in the Seanad today, and there will be a similar question in the Dáil tomorrow. However, I suggest to Senators that the Joint Committee on Health and Children might call in representatives of Alexion in order to help in a way that might be most effective by putting pressure on the company to do right by Irish taxpayers and patients.